Creating new treatments for antibiotic-resistant bacteria
Official title: Development of Therapeutic Products for Antibiotic Resistant Bacteria
Funded at Crestone, INC. · NIH-11111248 · Data updated 2026-11-12
This study is working on creating new treatments to help fight infections caused by tough bacteria that don't respond to regular antibiotics, so patients can have better options for getting better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Crestone, INC. NIH-funded |
| Lab location | 1 site (Boulder, United States) |
| Project start | July 1, 2020 |
| Project end | July 9, 2025 |
| Funding year | 2024 |
| Award (this year) | $970,628 |
| NIH project number | 75N93020C00020-P00009-9999-1 |
| Project ID | NIH-11111248 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
✕Less likely to help
Patients with infections that are not caused by antibiotic-resistant bacteria may not receive any benefit from this research.
What this research studies
This research focuses on developing new therapeutic products to combat antibiotic-resistant bacteria, which pose a significant threat to public health. The approach includes optimizing lead compounds, selecting the best candidates for further development, and conducting preclinical studies to ensure safety and efficacy. Patients may benefit from innovative treatments that could effectively target infections caused by resistant strains of bacteria, such as Staphylococcus aureus. The research aims to advance these products through rigorous testing and regulatory processes.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively combat infections caused by antibiotic-resistant bacteria.
How similar studies have gone: Other research has shown promise in developing treatments for antibiotic-resistant infections, indicating that this approach has potential for success.
Where this research is happening
-
Crestone, INC.
Boulder, United States Active
Researchers
- Principal investigator: Ochsner, Urs — Crestone, INC.
- Study coordinator: Ochsner, Urs
Related research
Other NIH-funded projects on the same topics.
-
Creating new treatments for infections that resist antibiotics
This study is looking for new treatments to help fight infections from tough bacteria, like Clostridioides difficile, and if you're interested, you might have a chance to join a trial testing these new options to see if they're safe and work well.
-
Creating new treatments for antibiotic-resistant bacteria
This study is working on creating new treatments to help fight infections caused by antibiotic-resistant bacteria, so that patients can have better options for getting well.
-
Developing new treatments for antibiotic-resistant infections and emerging diseases
This study is working on new treatments to help people with infections that don't respond to regular antibiotics, so if you're struggling with tough-to-treat bacteria, this research could lead to better options for you in the future.
-
Creating new treatments for antibiotic-resistant infections
This study is working on a new treatment to help fight infections caused by antibiotic-resistant bacteria, which could give patients more options when current medicines don't work.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.